Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 18 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

67%

12 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

Phase 3
6(40.0%)
Phase 4
6(40.0%)
N/A
3(20.0%)
15Total
Phase 3(6)
Phase 4(6)
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials
NCT06088121Not ApplicableRecruiting

Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia

Role: collaborator

NCT07491029Not ApplicableNot Yet Recruiting

AI-based Customized tDCS for Finger Motor Recovery After Subacute Stroke

Role: collaborator

NCT07373145Recruiting

Prospective CT Assessment After DCB

Role: collaborator

NCT07091773Not ApplicableNot Yet Recruiting

A Clinical Trial to Evaluate the Safety and Effectiveness of OLIZ, a Photobiomodulation Medical Device for Surgical Site Pain Relief in Patients After Total Knee Arthroplasty

Role: collaborator

NCT06081803Phase 3Active Not Recruiting

Evolocumab in STEMI

Role: collaborator

NCT06990568Phase 4Not Yet Recruiting

Impact of Probiotics on Antibiotic-associated Diarrhea in Community-acquired Pneumonia

Role: lead

NCT02799368Phase 3Completed

Balanced Salt Solution Versus 0.9% Saline Infusion for Prevention of Contrast-induced Acute Kidney Injury (BASIC Trial)

Role: collaborator

NCT03357653Phase 3Unknown

Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1

Role: collaborator

NCT02657980Phase 3Completed

The Effect of tDCS in Patients With Moderate to Severe Major Depressive Disorder

Role: collaborator

NCT01672476Phase 3Completed

A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension

Role: collaborator

NCT02350959Phase 4Unknown

Adverse Plaque Characteristics in CCTA and TVC Imaging

Role: lead

NCT02364466Unknown

Cohort of Peripheral T Cell Lymphoma

Role: collaborator

NCT01829022Completed

Multi-center Prospective Study on E-NOTES for Myomectomy With Traction of Multidirectional Sutures

Role: collaborator

NCT02011659Phase 3Unknown

Long Term Prevention of Nausea and Vomiting in Gynecologic Laparoscopy

Role: lead

NCT01903902Phase 4Unknown

Efficacy and Safety of Paclitaxel-eluting Balloon for Treatment of Lesions in Native Small Coronary Arteries

Role: collaborator

NCT01871792Phase 4Unknown

Preventive Effect of Pitavastatin on Contrast-Induced Nephropathy in Patients With Renal Dysfunction

Role: collaborator

NCT01579500Phase 4Completed

Neuropathic Pain Study With Botulinum Toxin A in Spinal Cord Injury Patients

Role: collaborator

NCT01378104Phase 4Completed

100% VS 80% Of Pegasys In Koreans With Chronic Hepatitis C (CHC)

Role: collaborator

All 18 trials loaded